Literature DB >> 19962618

Patient questionnaires in rheumatoid arthritis: advantages and limitations as a quantitative, standardized scientific medical history.

Theodore Pincus1, Yusuf Yazici, Martin J Bergman.   

Abstract

In many chronic diseases, objective gold standard measures such as blood pressure, cholesterol, and bone densitometry often provide most of the information used to establish a diagnosis and guide therapy. By contrast, in inflammatory rheumatic diseases, information from a patient history usually is considerably more prominent in clinical management. Patient history data can be recorded as standardized, quantitative scientific data through use of validated self-reported questionnaires. Patient questionnaires address the primary concerns of patients and their families. Questionnaire scores distinguish active from control treatments in clinical trials at similar levels to swollen and tender joint counts or laboratory tests. Patient questionnaire data are correlated significantly with joint counts, radiographic scores, and laboratory tests, but usually are far more significant than these measures in the prognosis of severe outcomes of rheumatoid arthritis (RA), including work disability, costs, and premature death. Limitations of patient questionnaires are based on cultural features involving variation in responses among ethnic groups, and a need for translation, although translated questionnaires can be as valuable as a translator. Patient questionnaires do not replace further medical history, physical examination, laboratory tests, and imaging data, and they require interpretation in a context of these standard sources of information at any clinical encounter. Patient questionnaires are useful to monitor patient status in usual clinical care, with almost no effort on the part of the physician and staff if distributed by the receptionist in the infrastructure of office practice.

Entities:  

Mesh:

Year:  2009        PMID: 19962618     DOI: 10.1016/j.rdc.2009.10.009

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

1.  Validity and responsiveness of the Michigan Hand Questionnaire in patients with rheumatoid arthritis: a multicenter, international study.

Authors:  Jennifer F Waljee; Kevin C Chung; H Myra Kim; Patricia B Burns; Frank D Burke; E F Shaw Wilgis; David A Fox
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-02       Impact factor: 4.794

2.  Development of a brief, 12-item version of the Michigan Hand Questionnaire.

Authors:  Jennifer F Waljee; H Myra Kim; Patricia B Burns; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

3.  An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritis.

Authors:  Perry M Nicassio; Morgan A Kay; Mara K Custodio; Michael R Irwin; Richard Olmstead; Michael H Weisman
Journal:  J Psychosom Res       Date:  2011-05-14       Impact factor: 3.006

4.  Association between rheumatoid arthritics and osteoporosis among Chinese men, a community based study.

Authors:  Hui-Hong Piao; Ke-Qin Zhang; Zi-Hui Tang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Long-term followup for rheumatoid arthritis patients in a multicenter outcomes study of silicone metacarpophalangeal joint arthroplasty.

Authors:  Kevin C Chung; Patricia B Burns; H Myra Kim; Frank D Burke; E F Shaw Wilgis; David A Fox
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

6.  Responsiveness of the Korean version of the Michigan Hand Outcomes Questionnaire after carpal tunnel release.

Authors:  Seung Myung Wi; Hyun Sik Gong; Kee Jeong Bae; Young Hak Roh; Young Ho Lee; Goo Hyun Baek
Journal:  Clin Orthop Surg       Date:  2014-05-16

7.  Usefulness of patients-reported outcomes in rheumatoid arthritis focus group.

Authors:  Jenny Amaya-Amaya; Diana Botello-Corzo; Omar-Javier Calixto; Rolando Calderón-Rojas; Aura-Maria Domínguez; Paola Cruz-Tapias; Gladis Montoya-Ortiz; Ruben-Dario Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  Arthritis       Date:  2012-09-28

8.  GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.

Authors:  Isabel Castrejón; Theodore Pincus; Martin Soubrier; Yih Chang Lin; Anne-Christine Rat; Bernard Combe; Maxime Dougados
Journal:  Rheumatology (Oxford)       Date:  2013-07-17       Impact factor: 7.580

9.  Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.

Authors:  Nathalie Carrier; Anthony Marotta; Artur J de Brum-Fernandes; Patrick Liang; Ariel Masetto; Henri A Ménard; Walter P Maksymowych; Gilles Boire
Journal:  Arthritis Res Ther       Date:  2016-02-01       Impact factor: 5.156

10.  Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.

Authors:  Nathalie Carrier; Artur J de Brum-Fernandes; Patrick Liang; Ariel Masetto; Sophie Roux; Norma K Biln; Walter P Maksymowych; Gilles Boire
Journal:  RMD Open       Date:  2020-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.